Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
152M
-
Number of holders
-
189
-
Total 13F shares, excl. options
-
124M
-
Shares change
-
+5.51M
-
Total reported value, excl. options
-
$995M
-
Value change
-
+$16.4M
-
Put/Call ratio
-
0.36
-
Number of buys
-
108
-
Number of sells
-
-86
-
Price
-
$8.09
Significant Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) as of Q2 2022
235 filings reported holding ADPT - Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share as of Q2 2022.
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) has 189 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 124M shares
of 152M outstanding shares and own 81.36% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (30M shares), PRICE T ROWE ASSOCIATES INC /MD/ (12.2M shares), VANGUARD GROUP INC (11.6M shares), Matrix Capital Management Company, LP (11.6M shares), ARK Investment Management LLC (8.77M shares), Sumitomo Mitsui Trust Holdings, Inc. (4.62M shares), Nikko Asset Management Americas, Inc. (4.62M shares), Bellevue Group AG (3.54M shares), Blue Water Life Science Advisors, LP (3.12M shares), and STATE STREET CORP (2.34M shares).
This table shows the top 189 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.